Your browser's JavaScript is disabled.

To properly view the content on this page, please enable JavaScript.

Publications

Imetelstat

All Publications

The preclinical efficacy of a novel telomerase inhibitor, imetelstat, in AML: A randomized trial in patient-derived xenografts

Imetelstat Non-clinical Imetelstat

Bruedigam C, et al.

Telomerase Inhibition with Imetelstat Eradicates β-catenin Activated BC CML Stem Cells

Imetelstat Non-clinical Imetelstat

Ma W, et al.

Myelosuppression in Patients Treated With the Telomerase Inhibitor Imetelstat is Not Mediated Through Activation of Toll-Like Receptors

Imetelstat Non-clinical Imetelstat

Baerlocher GM, et al.

Impact of Hypomethylating Agents on hTERT Expression and Synergistic Effect in Combination With Imetelstat, a Telomerase Inhibitor, in Acute Myeloid Leukemia Cell Lines

Imetelstat Non-clinical Imetelstat

Rusbuldt J, et al.

Telomerase in hematologic malignancies

Imetelstat Telomerase

Current Opinion in Hematology 2016

Bruedigam C, et al.

Imetelstat Therapy in Refractory Anemia with Ring Sideroblasts with or without Thrombocytosis

Clinical Imetelstat: MDS Imetelstat

Blood Cancer Journal 2016

Tefferi A, et al.

Telomerase Inhibitor Imetelstat Therapy in Refractory Anemia with Ring Sideroblasts with or without Thrombocytosis

Clinical Imetelstat: MDS Imetelstat

Tefferi A, et al.

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

Imetelstat

New England Journal of Medicine 2015

Tefferi A, et al.

Imetelstat, a Telomerase Inhibitor, Therapy for Myelofibrosis: A Pilot Study

Clinical Imetelstat: MF Imetelstat

Tefferi A, et al.

Imetelstat (GRN163L), a Telomerase Inhibitor Selectively Affects Malignant Megakaryopoiesis in Myeloproliferative Neoplasms (MPN)

Imetelstat Non-clinical Imetelstat

Iancu-Rubin C, et al.

[facetwp facet="publication_load_more"]